Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Diabetic Gastroparesis: early-phase trial registry
2 of 8 indexed Diabetic Gastroparesis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Diabetic Gastroparesis: 8 US clinical trials tracked, 2 recruiting.
Diabetic Gastroparesis is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins Bloomberg School of Public Health, running 2 of these trials.
Enrollment posture brief
Registry condition diabetic-gastroparesis
OPEN 2 | RECR 25% | LATE 0 | EARLY 5 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)
Diabetic Gastroparesis lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Diabetic Gastroparesis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Diabetic Gastroparesis is recruiting below its size-band peers.
2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Diabetic Gastroparesis research.
Johns Hopkins Bloomberg School of Public Health accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Diabetic Gastroparesis enrolment sits around 150 participants.
Median target enrolment is 150 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.
-
Diabetic Gastroparesis research is mostly interventional.
6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
Johns Hopkins Bloomberg School of Public Health
NCT04661215
Thoracic Neuromodulation for Diabetic Gastroparesis
Medical University of South Carolina
NCT05273788
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
CinDome Pharma
NCT05832151
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
Millennium Pharmaceuticals
NCT03544229
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
Neurogastrx
NCT04303195
G-POEM for Treatment of Refractory Gastroparesis
Johns Hopkins University
NCT02732821
Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis
Johns Hopkins Bloomberg School of Public Health
NCT01030341
Biomagnetic Characterization of Gastric Dysrhythmias III
Vanderbilt University Medical Center
NCT03176927
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Diabetic Gastroparesis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Diabetic Gastroparesis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Diabetic Gastroparesis page
8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Diabetic Gastroparesis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Johns Hopkins Bloomberg School of Public Health sponsors the most Diabetic Gastroparesis trials on record, review their full trial history before evaluating a specific study. See Johns Hopkins Bloomberg School of Public Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Gastroparesis condition card totals 8 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.